Skip to main content
Equibles

Swiss National Bank

Bank

Position in CGEM — Cullinan Therapeutics, Inc.

CIK 1582202 ZURICH, V8
Back to CGEM Full portfolio

Position in CGEM

as of Jun 30, 2026 · filed Aug 11, 2026
Position Value
$1,383,960
+$555,517 QoQ
Shares Held
76,000
+30.4% QoQ
Ownership
0.118%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#66
of 183 holders
Holding Since
Jun 2021
21 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in CGEM Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Swiss National Bank holds $1,800,323,370 across 152 Biotechnology names. CGEM ranks #124 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 717,440 $356,373,971
2 REGN
Regeneron Pharmaceuticals, Inc.
 293,020 $182,709,690
3 ALNY
Alnylam Pharmaceuticals, Inc.
 374,080 $112,609,302
4 RVMD
Revolution Medicines, Inc.
 456,331 $85,461,669
5 RPRX
Royalty Pharma plc
 1,159,800 $65,029,986
6 INSM
INSMED Inc
 593,512 $63,280,249
7 INCY
Incyte Corp
 476,874 $54,058,436
8 MRNA
Moderna, Inc.
 679,900 $47,613,397

All Filings in CGEM

Export CSV
21 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,383,960 76,000
2026-03-31 $828,443 58,300
2025-12-31 $603,405 58,300
2025-09-30 $298,279 50,300
2025-06-30 $378,759 50,300
2025-03-31 $474,639 62,700
2024-12-31 $763,686 62,700
2024-09-30 $1,232,064 73,600
2024-06-30 $1,283,584 73,600
2024-03-31 $788,952 46,300
2023-12-31 $471,797 46,300
2023-09-30 $349,330 38,600
2023-06-30 $415,336 38,600
2023-03-31 $302,808 29,600
2022-12-31 $348,150 33,000
2022-09-30 $396,138 30,900
2022-06-30 $396,138 30,900
2022-03-31 $379,014 36,200
2021-12-31 $516,905 33,500
2021-09-30 $645,502 28,600
2021-06-30 $736,450 28,600